| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.086 | 0.003 |